Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

First meningitis B vaccine could be available in UK next year.

Iacobucci G.

BMJ. 2012 Nov 20;345:e7867. doi: 10.1136/bmj.e7867. No abstract available.

PMID:
23169828
2.

Quadrivalent meningococcal conjugate vaccines.

Pace D, Pollard AJ, Messonier NE.

Vaccine. 2009 Jun 24;27 Suppl 2:B30-41. doi: 10.1016/j.vaccine.2009.05.003. Epub 2009 May 27. Review.

PMID:
19477560
3.

The discovery and development of a novel vaccine to protect against Neisseria meningitidis Serogroup B Disease.

Zlotnick GW, Jones TR, Liberator P, Hao L, Harris S, McNeil LK, Zhu D, Perez J, Eiden J, Jansen KU, Anderson AS.

Hum Vaccin Immunother. 2015;11(1):5-13. doi: 10.4161/hv.34293. Epub 2014 Nov 1. Review.

4.

Neisseria meningitidis serogroup B vaccine development.

Caesar NM, Myers KA, Fan X.

Microb Pathog. 2013 Apr;57:33-40. doi: 10.1016/j.micpath.2013.02.003. Epub 2013 Feb 14. Review. Erratum in: Microb Pathog. 2013 Jun-Jul;59-60:60.

PMID:
23416222
5.

Meningococcal serogroup B infections: a search for a broadly protective vaccine.

Vermont CL, van den Dobbelsteen GP.

Expert Rev Vaccines. 2003 Oct;2(5):673-81. Review.

PMID:
14711328
6.

Towards an improved serogroup B Neisseria meningitidis vaccine.

Perrett KP, Pollard AJ.

Expert Opin Biol Ther. 2005 Dec;5(12):1611-25. Review.

PMID:
16318425
7.

Advances towards the prevention of meningococcal B disease: a multidimensional story.

Roderick M, Finn A.

J Infect. 2014 Jan;68 Suppl 1:S76-82. doi: 10.1016/j.jinf.2013.09.026. Epub 2013 Oct 16. Review.

PMID:
24139188
8.

Use of a multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) for bacterial meningitis prevention.

Esposito S, Castellazzi L, Bosco A, Musio A, Stoddard J.

Immunotherapy. 2014;6(4):395-408. doi: 10.2217/imt.14.11. Review.

PMID:
24815780
9.

Neisseria meningitidis B vaccines: recent advances and possible immunization policies.

Gasparini R, Amicizia D, Domnich A, Lai PL, Panatto D.

Expert Rev Vaccines. 2014 Mar;13(3):345-64. doi: 10.1586/14760584.2014.880341. Epub 2014 Jan 29. Review.

PMID:
24476428
10.

Challenges and progress in the development of a serogroup B meningococcal vaccine.

Lewis S, Sadarangani M, Hoe JC, Pollard AJ.

Expert Rev Vaccines. 2009 Jun;8(6):729-45. doi: 10.1586/erv.09.30. Review.

PMID:
19485754
11.

Neisseria meningitidis B vaccines.

Panatto D, Amicizia D, Lai PL, Gasparini R.

Expert Rev Vaccines. 2011 Sep;10(9):1337-51. doi: 10.1586/erv.11.103. Review.

PMID:
21919622
12.

Meningococcal B Vaccination (4CMenB) in Infants and Toddlers.

Esposito S, Tagliabue C, Bosis S.

J Immunol Res. 2015;2015:402381. doi: 10.1155/2015/402381. Epub 2015 Aug 17. Review.

13.

Prospects for eradication of meningococcal disease.

Nadel S.

Arch Dis Child. 2012 Nov;97(11):993-8. doi: 10.1136/archdischild-2012-302036. Epub 2012 Sep 15. Review.

14.

Serogroup B meningococcal vaccines.

Zimmer SM, Stephens DS.

Curr Opin Investig Drugs. 2006 Aug;7(8):733-9. Review.

PMID:
16955685
15.

Vaccines for the prevention of meningococcal disease in children.

Soriano-GabarrĂ³ M, Stuart JM, Rosenstein NE.

Semin Pediatr Infect Dis. 2002 Jul;13(3):182-9. Review.

PMID:
12199614
16.

[Active immunization against serogroup B Neisseria meningitidis].

Navarro-Alonso JA.

Enferm Infecc Microbiol Clin. 2003 Nov;21(9):513-9. Review. Spanish.

PMID:
14572386
17.

[Immune response to anti-meningococcal vaccines].

Milagres LG, Melles CE.

Rev Saude Publica. 1993 Jun;27(3):221-6. Review. Portuguese.

PMID:
8115838
18.

Multivalent meningococcal serogroup B vaccines: challenges in predicting protection and measuring effectiveness.

Poolman JT, Richmond P.

Expert Rev Vaccines. 2015;14(9):1277-87. doi: 10.1586/14760584.2015.1071670. Epub 2015 Jul 23. Review.

PMID:
26204792
19.

[The outlook for the development of a vesicular meningococcal serogroup B vaccine].

Del'vig AA, Semenov BF.

Zh Mikrobiol Epidemiol Immunobiol. 1998 Jan-Feb;(1):91-6. Review. Russian. No abstract available.

PMID:
9532701
20.

The multicomponent meningococcal serogroup B vaccine (4CMenB): origin, composition, health impact and unknown aspects.

Mameli C, Galli E, Mantegazza C, Fabiano V, Zuccotti GV.

Future Microbiol. 2015;10(10):1579-98. doi: 10.2217/fmb.15.91. Epub 2015 Oct 6. Review.

PMID:
26437903

Supplemental Content

Support Center